Award
Delivery Order #SPE2DR26F5RKU
Short-Term Pharmaceutical Delivery Order for Novolog Insulin Vials
Buyer
Defense Logistics Agency
Award Amount
$1,318.20
Ceiling
$1,318.20
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26F5RKU
NAICS
424210
This award is a delivery order contract issued under a larger Indefinite Delivery Vehicle (IDV) held by AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company. The contract specifically procures Novolog insulin in 100 unit/ml 10ml vials, a critical medication for diabetes management. The contract's significance lies in ensuring timely and reliable delivery of essential pharmaceutical products to support healthcare programs. The scope of work includes the receipt, handling, and delivery of the specified insulin vials to the designated location in Conshohocken, PA, within a brief performance period spanning a single day. This delivery order follows a competitive procurement under the parent IDV contract, which spans from 2025 to 2036, established to streamline pharmaceutical supply logistics. No subcontractors or additional solicitation details are noted for this specific delivery order.
Description
4571086354!NOVOLOG 100 UNIT/ML VIAL 10ML